U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07853365) titled 'Predictors of Treatment Outcome in Major Depressive Disorder' on Sept. 26.
Brief Summary: Major depressive disorder (MDD) is a common and disabling mental health condition characterized by persistent low mood, loss of interest, and disruptions in sleep, appetite, and daily functioning. Response to treatment varies widely among individuals: while some respond to standard single-drug antidepressant therapy, others require medication combinations or electroconvulsive therapy (ECT). Currently, reliable clinical tools to predict which patients will respond best to specific treatment modalities remain limited.
The purpose of this prospect...